IRIS
POSTORINO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.217
EU - Europa 2.204
AS - Asia 2.093
SA - Sud America 309
Continente sconosciuto - Info sul continente non disponibili 260
AF - Africa 41
OC - Oceania 5
Totale 21.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.116
SG - Singapore 844
IT - Italia 632
CN - Cina 472
DE - Germania 445
RU - Federazione Russa 260
BR - Brasile 250
UA - Ucraina 205
VN - Vietnam 185
HK - Hong Kong 168
BD - Bangladesh 166
IE - Irlanda 144
GB - Regno Unito 109
FR - Francia 104
SE - Svezia 77
FI - Finlandia 72
JP - Giappone 65
CA - Canada 63
KR - Corea 52
IN - India 42
NL - Olanda 37
PL - Polonia 30
ES - Italia 21
AT - Austria 19
ZA - Sudafrica 17
AR - Argentina 15
UZ - Uzbekistan 13
EC - Ecuador 12
MX - Messico 12
ID - Indonesia 11
IQ - Iraq 11
BE - Belgio 10
PH - Filippine 10
TR - Turchia 10
UY - Uruguay 9
CO - Colombia 8
CZ - Repubblica Ceca 7
LT - Lituania 6
MA - Marocco 6
NI - Nicaragua 6
RO - Romania 6
VE - Venezuela 6
CR - Costa Rica 5
EG - Egitto 5
KE - Kenya 5
KG - Kirghizistan 5
PK - Pakistan 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CL - Cile 4
DZ - Algeria 4
GT - Guatemala 4
IR - Iran 4
JM - Giamaica 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
PE - Perù 2
PY - Paraguay 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
ET - Etiopia 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 20.873
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.172
Wilmington 3.749
Houston 3.207
Ashburn 532
Singapore 479
Fairfield 445
Chandler 344
San Jose 336
Ann Arbor 330
Beijing 191
Seattle 178
New York 174
Hong Kong 167
Jacksonville 163
Rome 156
Cambridge 150
Dublin 137
Council Bluffs 123
Medford 98
Dearborn 97
Los Angeles 91
Santa Clara 86
Dallas 80
The Dalles 78
Tokyo 58
Ho Chi Minh City 55
Buffalo 46
Lawrence 46
Hanoi 44
Zhengzhou 43
Milan 40
Munich 37
Chicago 36
Orem 35
Moscow 34
Lauterbourg 33
San Diego 32
Denver 26
Phoenix 25
Atlanta 23
São Paulo 23
Naples 19
Helsinki 18
Menlo Park 18
Montreal 18
Mülheim 17
Bologna 16
Shanghai 16
Warsaw 16
Toronto 15
Chennai 14
Hefei 14
San Francisco 14
Johannesburg 13
London 13
Nuremberg 13
Bari 12
Engelhard 12
Frankfurt am Main 12
Redondo Beach 12
Boardman 11
Brooklyn 11
Creede 11
Del Norte 11
Stockholm 11
Nanjing 10
Palo Alto 10
Poplar 10
Amsterdam 9
Brussels 9
Kraków 9
Rio de Janeiro 9
Turku 9
University Park 9
Vienna 9
Center 8
Charlotte 8
Da Nang 8
Haiphong 8
Kunming 8
Lappeenranta 8
Mountain View 8
North Bergen 8
Porto Alegre 8
Trieste 8
Columbus 7
Falls Church 7
Florence 7
Jakarta 7
Manchester 7
Montevideo 7
New Delhi 7
Norwalk 7
Palermo 7
Belo Horizonte 6
Brasília 6
Genoa 6
Guangzhou 6
Managua 6
Mumbai 6
Totale 16.808
Salva come PNG Salva come JPEG
Nome #
Autodeterminazione e responsabilità sanitaria: le trasfusioni di sangue nei pazienti Testimoni di Geova. 784
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 527
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 522
An allele-specific RT-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia 515
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 511
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 498
Red blood cell depletion of cord blood using hydroxyethylstarch double sedimentation: analysis of 40 cases 486
Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools, Prophylaxis, and Therapy. 485
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 481
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 477
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 477
Clonal evolution in therapy-related neoplasms 470
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 460
SEQUENTIAL THERAPY WITH VAPLD AND BORTEZOMIB AS INDUCTION THERAPY FOR MULTIPLE MYELOMA: A PHARMACOLOGIC COMBINATION TO ACHIEVE COMPLETE REMISSION BEFORE STEM CELL MOBILIZATION 459
SEQUENTIAL THERAPY WITH VAD, BORTEZOMIB AND CYCLOPHOSPHAMIDE AS INDUCTION THERAPY FOR MULTIPLE MYELOMA: A SEQUENTIAL PHARMACOLOGIC COMBINATION TO ACHIEVE COMPLETE REMISSIONS BEFORE STEM CELL TRANSPLANTATION 457
The therapeutic use of cord blood 454
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy 451
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 450
Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation 446
Cytokine removal under hemodiafiltration with endogenous reinfusion in acute kidney injury secondary to angioimmunoblastic T-cell lymphoma: a case report 441
Simultaneous occurrence of BCR/ABL1 and RUNX1/RUNX1T1 in a case of therapy-related acute myeloid leukemia 426
Percutaneus osteoplasty in the treatment of extraspinal painful multiple myeloma lesions. 424
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 421
Percutaneous kyphoplasty: indications and technique in the treatment of vertebral fractures from myeloma 419
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 419
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 417
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 414
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 413
High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma 408
Percutaneus osteoplasty in the treatment of extraspinal painful multiple myeloma lesions 403
Treatment of Acute Myeloid Leukemia with 20-30% Bone Marrow Blasts 398
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias 396
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 383
Extensive toxic epidermal necrolysis following brentuximab vedotin administration 382
Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia 379
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 365
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 362
Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia. 359
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 352
Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients 320
Molecular expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinases in plasmacellular disorders: A molecular panel to nvestigate disease progression 287
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 227
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 180
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 169
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia 162
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 159
CT Images in Follicular Lymphoma: Changes after Treatment Are Predictive of Cardiac Toxicity in Patients Treated with Anthracycline-Based or R-B Regimens 144
18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study 143
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study 134
Telemedicine as a Medical Examination Tool During the Covid-19 Emergency: The Experience of the Onco-Haematology Center of Tor Vergata Hospital in Rome 122
Pathogenetic mechanism of macular edema during a treatment with ibrutinib: a case presentation 103
Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review 101
Body composition in patients with follicular lymphoma: asso-ciations between changes in radiomic parameters in patients treated with R-CHOP-like and R-B regimens: LyRa 01F 99
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study 95
Sustained Remission in Relapsed/Refractory Diffuse Large B Cell Lymphoma Following Glofitamab Discontinuation Due to JC Virus Reactivation: Balancing Efficacy and Infectious Risk 90
Co-occurrence of angioimmunoblastic T-cell lymphoma and aggressive-refractory plasma-cell neoplasm: Two new cases and literature review 88
Complete remission induced by rituximab-lenalidomide, following CAR-T cell failure, is not associated with CAR-T cell re-expansion in the peripheral blood 87
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia 86
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia 86
Association of [18F]-FDG PET/CT-Derived Radiomic Features with Clinical Outcomes and Genomic Profiles in Patients with Chronic Lymphocytic Leukemia 81
Coexistence of T-Large Granular Lymphocyte Leukemia and Peripheral T Cell Lymphoma-NOS with Indolent Behavior 79
The contribution of IL-10 and IL-6 as potential biomarkers for detecting central nervous system involvement in non-Hodgkin lymphomas 74
Vitamin D and non-Hodgkin lymphomas, trends from an Italian monocentric study 68
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens 67
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib? 65
Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial 65
Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study 65
COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients 63
COVID-19 vaccination: evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients 61
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 59
CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience 55
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 51
null 3
Totale 21.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022418 0 0 0 31 11 46 18 31 49 37 36 159
2022/2023815 71 69 63 104 47 150 83 71 91 9 41 16
2023/2024496 37 8 30 7 65 164 58 31 9 9 6 72
2024/20251.366 79 251 147 61 30 89 75 133 126 116 117 142
2025/20263.117 255 165 310 283 285 138 323 328 369 302 168 191
2026/2027929 167 137 485 140 0 0 0 0 0 0 0 0
Totale 21.129